Fucoidan for Managing and Treating Dementia

View at publisher Summarise with VIRAT
Authors: Mosunmola Busayo Oyeleke, Ahmed Olalekan Bakare
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder, and the most common cause of dementia. It occurs as a result of build-up of abnormal proteins and is characterized by two neuropathological hallmarks, amyloid beta deposition, and aggregation of phosphorylated tau. The major causes of AD are not fully known; however, it believed to be caused by some factors, including, but not limited to, genetic, environmental, and lifestyle modifications. AD is a progressive type of disease that makes individuals living with it to live a dependent life, which could be frustrating to both the patients and caregivers. Recently, there's no available cure for AD, although, there are some medications used for its management, however, with some adverse side effects. Therefore, the quest for AD drug discovery development has been ongoing for decades. Natural products have been recommended to be employed in experimental research to combat AD through the use of transgenic mice or induction of AD-like symptoms because they present with minimal side effects. Fucoidan is the general name for sulfated glycans obtained from brown seaweeds. They possess antioxidant, anti-inflammatory, anticholinergic, together with cognitive enhancing functions. Above all, they are responsible for the production of favorable gut microbiota via an increase in short-chain fatty acids production. Hence, they have been recommended to have the potential of relieving AD-like symptoms and been incorporated into AD drug discovery research. This chapter explores some mechanistic actions of fucoidan in carrying out its antidementia properties in AD research both in vivo and in vitro .

Fields of Study & Subjects

Seaweed-derived Bioactive Compounds Alzheimer's disease research and treatments Medicinal Plants and Neuroprotection

Publication details

Journal / source
CRC Press eBooks
Pages
137–142
Publication date
31 March 2026
Language
EN
Document type
Book chapter